S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Clinical trial NCT03418961 · RECRUITING

Trial details

NCT number: NCT03418961
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiotoxicity HER2/Neu Positive Metastatic Malignant Neoplasm in the Brain Recurrent Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7

Start date: 2017-11-01
Primary completion: 2027-09-15
Enrollment: 491

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.